跳至主要内容
临床试验/JPRN-UMIN000017975
JPRN-UMIN000017975招募中未知

antiretroviral therapy regimen intensified with maraviroc during early HIV-1 infection - ART intensified by MVC with early HIV-1 infection

ational Hospital Organization Osaka National Hospital0 个研究点目标入组 30 人开始时间: 2015年6月19日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) coronary diseases: unstable angina or history of acute myocardial infarction within 6 months before entry 2) Viral hepatitis (HBV,HCV) 3) Any verified Grade 4 laboratory abnormality (excluding abnormal lipid metabolism) 4)Alanine aminotransferase (ALT) greater than 5 times the upper limit of normal 5) Subject has creatinine clearance of less than 50 mL/min via Cockroft-Gault method 6)Any evidence of primary viral resistance based on the presence of any major resistance-associated mutation [IAS-USA, 2014] in the Screening result or, if known, any historical resistance test results 7) Women who are pregnant or sexually active without effective contraception 8) Subjects whom investigators consider to be inappropriate to enroll in the study

研究者

发起方
ational Hospital Organization Osaka National Hospital

相似试验

已完成
不适用
Highly active anti-retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial.
ISRCTN81305260Institute of Biomedical Investigations of Bellvitge (Institut d'Investigació Biomèdica de Bellvitge) (IDIBELL) (Spain)308
已完成
不适用
Highly Active Antiretroviral Treatment (HAART) of Human Immunodeficiency Virus (HIV)-infection in a town in Cameroon: randomised controlled study to suggest which treatment starting point is most beneficial for the patientsHIV infectionInfections and InfestationsHIV
ISRCTN22114173Institute of Community Medicine, University of Tromsø (Norway)100
已完成
不适用
Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trial
ISRCTN48682427Ministry of Health (Brazil)
已完成
不适用
Impact of highly active anti-retroviral therapy (HAART) during pregnancy and breastfeeding on mother-to-child transmission (MTCT) and mother's healthHuman immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)Infections and InfestationsHuman immunodeficiency virus (HIV)
ISRCTN71468401World Health Organization (WHO) (Switzerland)2,400
尚未招募
不适用
Promoting Adherence to Anti-retroviral Therapy and Viral suppression among HIV positive Young People in Uganda through Group Support PsychotherapyMental and Behavioural Disorders
PACTR202006601935462CRI Foundation120